Tesaro, Inc. (TSRO) on Focus After Trading At 52-Week Lows

May 9, 2018 - By James Guidry

Tesaro, Inc. (NASDAQ:TSRO) Logo

Investors sentiment decreased to 1.01 in Q4 2017. Its down 0.20, from 1.21 in 2017Q3. It dropped, as 46 investors sold Tesaro, Inc. shares while 64 reduced holdings. 39 funds opened positions while 72 raised stakes. 57.95 million shares or 0.57% less from 58.28 million shares in 2017Q3 were reported.
139,100 are held by Swiss Retail Bank. Bluestein R H holds 0.01% of its portfolio in Tesaro, Inc. (NASDAQ:TSRO) for 2,500 shares. Federated Investors Inc Pa reported 0.07% of its portfolio in Tesaro, Inc. (NASDAQ:TSRO). Sumitomo Mitsui owns 109,142 shares or 0.01% of their US portfolio. Trellus Mgmt Ltd Liability Corp has 11,519 shares. Pennsylvania-based Sei Investments has invested 0.01% in Tesaro, Inc. (NASDAQ:TSRO). Intl Gru has 879 shares for 0% of their portfolio. Nomura Asset Mgmt Limited reported 4,000 shares or 0% of all its holdings. Oracle Mngmt Inc holds 14.64% of its portfolio in Tesaro, Inc. (NASDAQ:TSRO) for 891,242 shares. Proshare Advisors Limited Com invested in 30,324 shares. Argentiere Capital Ag stated it has 1.53% in Tesaro, Inc. (NASDAQ:TSRO). 3.62M were reported by Price T Rowe Assoc Md. Cap Impact Advsr Ltd Llc reported 9,841 shares. Ubs Asset Americas holds 345,305 shares. Sumitomo Mitsui Asset Limited accumulated 2,532 shares.

Since March 1, 2018, it had 9 buys, and 7 sales for $61.19 million activity. On Thursday, March 1 PEARSON TIMOTHY R sold $141,265 worth of Tesaro, Inc. (NASDAQ:TSRO) or 2,575 shares. $8.35 million worth of Tesaro, Inc. (NASDAQ:TSRO) was bought by Viswanathan Ravi on Friday, March 2. $8.35M worth of Tesaro, Inc. (NASDAQ:TSRO) shares were bought by MOTT DAVID M. Another trade for 145,532 shares valued at $8.35 million was bought by BASKETT FOREST. BARRETT M JAMES also bought $6.68 million worth of Tesaro, Inc. (NASDAQ:TSRO) shares. 145,532 shares were bought by SANDELL SCOTT D, worth $8.35 million on Friday, March 2.

The stock of Tesaro, Inc. (NASDAQ:TSRO) hit a new 52-week low and has $44.31 target or 4.00 % below today’s $46.16 share price. The 6 months bearish chart indicates high risk for the $2.53 billion company. The 1-year low was reported on May, 9 by Barchart.com. If the $44.31 price target is reached, the company will be worth $101.24M less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock.

The stock decreased 0.50% or $0.23 during the last trading session, reaching $46.16. About 1.31M shares traded or 24.46% up from the average. Tesaro, Inc. (NASDAQ:TSRO) has declined 63.82% since May 9, 2017 and is downtrending. It has underperformed by 75.37% the S&P500.

Tesaro, Inc. (NASDAQ:TSRO) Ratings Coverage

Among 15 analysts covering Tesaro (NASDAQ:TSRO), 12 have Buy rating, 0 Sell and 3 Hold. Therefore 80% are positive. Tesaro had 19 analyst reports since November 15, 2017 according to SRatingsIntel. Evercore upgraded the stock to “Outperform” rating in Thursday, February 22 report. The firm has “Outperform” rating by Leerink Swann given on Wednesday, November 15. The rating was maintained by Bank of America on Friday, May 4 with “Buy”. The rating was maintained by Argus Research on Wednesday, May 2 with “Buy”. On Wednesday, February 28 the stock rating was maintained by Leerink Swann with “Buy”. The rating was maintained by Barclays Capital with “Equal-Weight” on Wednesday, February 28. The firm earned “Hold” rating on Wednesday, February 28 by Cowen & Co. The stock of Tesaro, Inc. (NASDAQ:TSRO) earned “Hold” rating by Piper Jaffray on Monday, April 16. The firm has “Buy” rating given on Wednesday, January 3 by Guggenheim. H.C. Wainwright maintained the shares of TSRO in report on Friday, May 4 with “Buy” rating.

More notable recent Tesaro, Inc. (NASDAQ:TSRO) news were published by: Globenewswire.com which released: “TESARO Announces First-Quarter 2018 Operating Results” on May 03, 2018, also Seekingalpha.com with their article: “Tesaro: Time To Buy” published on April 13, 2018, Streetinsider.com published: “After-Hours Stock Movers 05/03: (CVGI) (VIAV) (SHAK) Higher; (FLR) (ANET) (TSRO) Lower (more…)” on May 03, 2018. More interesting news about Tesaro, Inc. (NASDAQ:TSRO) were released by: Globenewswire.com and their article: “TESARO Announces Participation in Two Investor Conferences” published on May 01, 2018 as well as Globenewswire.com‘s news article titled: “TESARO Summarizes TSR-042 Clinical Data Presented at AACR” with publication date: April 16, 2018.

Tesaro, Inc., an oncology-focused biopharmaceutical company, identifies, acquires, develops, and commercializes cancer therapeutics and oncology supportive care products in the United States. The company has market cap of $2.53 billion. It markets Rolapitant, a neurokinin-1, or NK-1, receptor antagonist for the prevention of chemotherapy induced nausea and vomiting under the VARUBI brand name. It currently has negative earnings. The firm is also developing Niraparib, an orally active and potent poly polymerase inhibitor, which is in various clinical trials to treat ovarian or breast cancers.

Tesaro, Inc. (NASDAQ:TSRO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: